STOCK TITAN
  1. Home
  2. News
  3. CTCX

Carmell Corporation - $CTCX STOCK NEWS

Welcome to our dedicated page for Carmell Corporation news (Ticker: $CTCX), a resource for investors and traders seeking the latest updates and insights on Carmell Corporation stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Carmell Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Carmell Corporation's position in the market.

News
Carmell Announces Successful Closing of $3.0 Million Private Placement
Rhea-AI Summary
Carmell (Nasdaq: CTCX) closed a private placement, raising $3 million. The company issued 1,331,452 shares of common stock at $2.88 per share for the CEO and $2.25 per share for other investors. Carmell will have approximately 20.58 million shares outstanding. The funds will support commercial launch efforts for their anti-aging bio-aesthetics technology products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.71%
Tags
none
-
News
Carmell Announces $3.0 Million Private Placement
Rhea-AI Summary
Carmell (Nasdaq: CTCX) announces a private placement of 1,333,333 common shares at $2.25 per share, generating $3 million in gross proceeds. CEO participates at $2.88 per share. Brookline Capital Markets acts as placement agent.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.72%
Tags
none
-
News
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
Rhea-AI Summary
Carmell (Nasdaq: CTCX) successfully closes the sale of subsidiary Axolotl Biologix, improving financial position and focusing on skincare product launch. The sale includes shares of common stock, preferred stock, and debt cancellation, leading to reduced cash burn, debt, EPS dilution, and increased tangible equity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.03%
Tags
none
News
Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary
Rhea-AI Summary
Carmell (Nasdaq: CTCX) announced the sale of its subsidiary, Axolotl Biologix, to the initial sellers for shares and notes worth $8 million. The move allows the company to focus on skincare products launch, following the acquisition of AxoBio in August 2023. The sale is expected to improve Carmell's financial position significantly.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.84%
Tags
none
-
News
Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field
Rhea-AI Summary
Carmell (Nasdaq: CTCX) announces Investor Webinar to unveil the Secretome technology in regenerative skin and haircare, featuring key opinion leaders and discussing market opportunities, scientific differentiation, and upcoming product launches.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
News
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024
Rhea-AI Summary
Carmell Corporation (Nasdaq: CTCX) announces the development of their Gold Limited Edition Exclusive skincare product for commercial launch in March 2024, along with 9 other skincare products. The products are based on the Carmell SecretomeTM, a cocktail of growth factors and proteins extracted from human platelets. The company also developed a micellar nanoparticle formulation to deliver ingredients without harmful excipients. Carmell is preparing to launch a Men's Skincare Line and a Haircare line, guided by a Scientific Advisory Board. The products are manufactured in-house in compliance with cGMP guidelines and surpass proposed FDA regulations. Carmell has established an online store for upcoming commercial operations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
28.92%
Tags
none
News
Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors
Rhea-AI Summary
Carmell Corporation (Nasdaq: CTCX) announced the addition of two independent directors to their Board. Scott Frisch, COO and CFO of AARP, brings extensive financial and operational experience. Dr. Gilles Spenlehauer, Scientific Director of SDTech Group, contributes diverse leadership roles in the chemical and pharmaceutical industries.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.17%
Tags
management
-
News
Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine
Rhea-AI Summary
Axolotl Biologix finalizes merger with Carmell Therapeutics, receiving an Initial Equity Value of $65 million, $8 million in cash and $57 million in CTCX stock. They also stand to gain up to $75 million in potential Milestone Equity Payments. The merger signifies a monumental step in regenerative medicine, with the combined force poised to become a market leader.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.67%
Tags
acquisition
-
News
Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics
Rhea-AI Summary
Carmell Corporation completes post-merger integration with Axolotl Biologix, projected post-merger savings of nearly $3 million per annum. Milestone payment of $8 million to Axolotl Biologix rescheduled to Aug 31, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.51%
Tags
acquisition
News
Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
acquisition
Stock CTCX logo
Carmell Corporation

Nasdaq:CTCX

CTCX Rankings

#4843 Ranked by Market Cap
#5319 Ranked by Stock Gains
N/A Ranked by Dividends

CTCX Stock Data

42.50M
17.80M
39.07%
13.72%
0.07%
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
United States of America
NEW YORK

About CTCX

alpcot agro is a swedish limited liability company and was incorporated in 2006. the company’s objective is to generate an attractive total return on invested capital by acquiring and farming agricultural land in russia and in other cis member states.